6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 6 of 6 clinical reviews.
Evidence-based review of empagliflozin (Jardiance) efficacy differences in South Asian populations, including pharmacogenomic factors, cardiovascular outcomes, and dosing considerations.
Evidence-based review of how empagliflozin safety, efficacy, and dosing considerations differ in South Asian populations, including pharmacogenomic factors, cardiovascular outcomes, and clinical monitoring guidance.
Ethnicity-stratified trial data, pharmacogenomics, and clinical guidance on empagliflozin efficacy differences in Black and African ancestry patients, reviewed by the HealthRX.com medical team.
Complete clinical guide to empagliflozin (Jardiance) dosing in East Asian patients, covering CYP2C19/CYP2D6 pharmacogenomics, BMI thresholds, EMPA-REG OUTCOME subgroup data, and practical prescribing recommendations.
A clinician-reviewed guide to empagliflozin (Jardiance) dosing, efficacy, and safety in Black and African ancestry patients, covering EMPA-REG OUTCOME subgroup data, G6PD prevalence, ACE inhibitor interactions, and CKD risk.
A clinician-level review of empagliflozin (Jardiance) efficacy differences in Hispanic and Latino patients, covering ethnicity-stratified trial subgroups, pharmacogenomics, SGLT2 transporter variants, and practical dosing considerations.